PIK3CA c.943A>G ;(p.T315A)

Variant ID: 3-178921461-A-G

NM_006218.2(PIK3CA):c.943A>G;(p.T315A)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Systematic review and meta-analysis of genomic alterations in acral melanoma.

Pigment Cell & Melanoma Research
Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL
Publication Date: 2022-05

Variant appearance in text: PI3K: T315A
PubMed Link: 35229492
Variant Present in the following documents:
  • PCMR-35-369-s003.xlsx, sheet 12
View BVdb publication page



Clonal evolution in breast cancer revealed by single nucleus genome sequencing.

Nature
Wang, Yong Y; Waters, Jill J; Leung, Marco L ML; Unruh, Anna A; Roh, Whijae W; Shi, Xiuqing X; Chen, Ken K; Scheet, Paul P; Vattathil, Selina S; Liang, Han H; Multani, Asha A; Zhang, Hong H; Zhao, Rui R; Michor, Franziska F; Meric-Bernstam, Funda F; Navin, Nicholas E NE
Publication Date: 2014-08-14

Variant appearance in text: PIK3CA: T315A
PubMed Link: 25079324
Variant Present in the following documents:
  • NIHMS607979-supplement-1.pdf
View BVdb publication page



Omics Screening for Pharmaceutical Efficacy and Safety in Clinical Practice.

Journal Of Pharmacogenomics & Pharmacoproteomics
Monte, Andrew A AA; Vasiliou, Vasilis V; Heard, Kennon J KJ
Publication Date: 2012-03-16

Variant appearance in text: PIK3CA: T315A
PubMed Link: 23264882
Variant Present in the following documents:
  • Main text
View BVdb publication page



Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Therapeutics And Clinical Risk Management
Henkes, Martin M; van der Kuip, Heiko H; Aulitzky, Walter E WE
Publication Date: 2008-02

Variant appearance in text: PI3K: Thr315Ala
PubMed Link: 18728706
Variant Present in the following documents:
  • Main text
  • tcrm-0401-163.pdf
View BVdb publication page